Cargando…

Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes

BACKGROUND: In the current SARS-CoV-2 pandemic, there has been worldwide debate on the use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of dexamethasone, a reduced 28-day mortality in patients requiring oxygen therapy or mechanical ventilation was shown. Their...

Descripción completa

Detalles Bibliográficos
Autores principales: van Paassen, Judith, Vos, Jeroen S., Hoekstra, Eva M., Neumann, Katinka M. I., Boot, Pauline C., Arbous, Sesmu M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735177/
https://www.ncbi.nlm.nih.gov/pubmed/33317589
http://dx.doi.org/10.1186/s13054-020-03400-9
_version_ 1783622605722353664
author van Paassen, Judith
Vos, Jeroen S.
Hoekstra, Eva M.
Neumann, Katinka M. I.
Boot, Pauline C.
Arbous, Sesmu M.
author_facet van Paassen, Judith
Vos, Jeroen S.
Hoekstra, Eva M.
Neumann, Katinka M. I.
Boot, Pauline C.
Arbous, Sesmu M.
author_sort van Paassen, Judith
collection PubMed
description BACKGROUND: In the current SARS-CoV-2 pandemic, there has been worldwide debate on the use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of dexamethasone, a reduced 28-day mortality in patients requiring oxygen therapy or mechanical ventilation was shown. Their results have led to considering amendments in guidelines or actually already recommending corticosteroids in COVID-19. However, the effectiveness and safety of corticosteroids still remain uncertain, and reliable data to further shed light on the benefit and harm are needed. OBJECTIVES: The aim of this systematic review and meta-analysis was to evaluate the effectiveness and safety of corticosteroids in COVID-19. METHODS: A systematic literature search of RCTS and observational studies on adult patients was performed across Medline/PubMed, Embase and Web of Science from December 1, 2019, until October 1, 2020, according to the PRISMA guidelines. Primary outcomes were short-term mortality and viral clearance (based on RT-PCR in respiratory specimens). Secondary outcomes were: need for mechanical ventilation, need for other oxygen therapy, length of hospital stay and secondary infections. RESULTS: Forty-four studies were included, covering 20.197 patients. In twenty-two studies, the effect of corticosteroid use on mortality was quantified. The overall pooled estimate (observational studies and RCTs) showed a significant reduced mortality in the corticosteroid group (OR 0.72 (95%CI 0.57–0.87). Furthermore, viral clearance time ranged from 10 to 29 days in the corticosteroid group and from 8 to 24 days in the standard of care group. Fourteen studies reported a positive effect of corticosteroids on need for and duration of mechanical ventilation. A trend toward more infections and antibiotic use was present. CONCLUSIONS: Our findings from both observational studies and RCTs confirm a beneficial effect of corticosteroids on short-term mortality and a reduction in need for mechanical ventilation. And although data in the studies were too sparse to draw any firm conclusions, there might be a signal of delayed viral clearance and an increase in secondary infections.
format Online
Article
Text
id pubmed-7735177
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77351772020-12-15 Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes van Paassen, Judith Vos, Jeroen S. Hoekstra, Eva M. Neumann, Katinka M. I. Boot, Pauline C. Arbous, Sesmu M. Crit Care Research BACKGROUND: In the current SARS-CoV-2 pandemic, there has been worldwide debate on the use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of dexamethasone, a reduced 28-day mortality in patients requiring oxygen therapy or mechanical ventilation was shown. Their results have led to considering amendments in guidelines or actually already recommending corticosteroids in COVID-19. However, the effectiveness and safety of corticosteroids still remain uncertain, and reliable data to further shed light on the benefit and harm are needed. OBJECTIVES: The aim of this systematic review and meta-analysis was to evaluate the effectiveness and safety of corticosteroids in COVID-19. METHODS: A systematic literature search of RCTS and observational studies on adult patients was performed across Medline/PubMed, Embase and Web of Science from December 1, 2019, until October 1, 2020, according to the PRISMA guidelines. Primary outcomes were short-term mortality and viral clearance (based on RT-PCR in respiratory specimens). Secondary outcomes were: need for mechanical ventilation, need for other oxygen therapy, length of hospital stay and secondary infections. RESULTS: Forty-four studies were included, covering 20.197 patients. In twenty-two studies, the effect of corticosteroid use on mortality was quantified. The overall pooled estimate (observational studies and RCTs) showed a significant reduced mortality in the corticosteroid group (OR 0.72 (95%CI 0.57–0.87). Furthermore, viral clearance time ranged from 10 to 29 days in the corticosteroid group and from 8 to 24 days in the standard of care group. Fourteen studies reported a positive effect of corticosteroids on need for and duration of mechanical ventilation. A trend toward more infections and antibiotic use was present. CONCLUSIONS: Our findings from both observational studies and RCTs confirm a beneficial effect of corticosteroids on short-term mortality and a reduction in need for mechanical ventilation. And although data in the studies were too sparse to draw any firm conclusions, there might be a signal of delayed viral clearance and an increase in secondary infections. BioMed Central 2020-12-14 /pmc/articles/PMC7735177/ /pubmed/33317589 http://dx.doi.org/10.1186/s13054-020-03400-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
van Paassen, Judith
Vos, Jeroen S.
Hoekstra, Eva M.
Neumann, Katinka M. I.
Boot, Pauline C.
Arbous, Sesmu M.
Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes
title Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes
title_full Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes
title_fullStr Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes
title_full_unstemmed Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes
title_short Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes
title_sort corticosteroid use in covid-19 patients: a systematic review and meta-analysis on clinical outcomes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735177/
https://www.ncbi.nlm.nih.gov/pubmed/33317589
http://dx.doi.org/10.1186/s13054-020-03400-9
work_keys_str_mv AT vanpaassenjudith corticosteroiduseincovid19patientsasystematicreviewandmetaanalysisonclinicaloutcomes
AT vosjeroens corticosteroiduseincovid19patientsasystematicreviewandmetaanalysisonclinicaloutcomes
AT hoekstraevam corticosteroiduseincovid19patientsasystematicreviewandmetaanalysisonclinicaloutcomes
AT neumannkatinkami corticosteroiduseincovid19patientsasystematicreviewandmetaanalysisonclinicaloutcomes
AT bootpaulinec corticosteroiduseincovid19patientsasystematicreviewandmetaanalysisonclinicaloutcomes
AT arboussesmum corticosteroiduseincovid19patientsasystematicreviewandmetaanalysisonclinicaloutcomes